Physician profile
Kathryn B Hook
NPI 1528450343
$3,522.29
in general payments reported to CMS, 2019-2025
16 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $434 · 2023: $991 · 2024: $906 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,955 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,954.60 |
| Education | $133.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,231.82 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $407.83 | 2023-2025 | Tezspire, Airsupra |
| Genzyme Corporation | $321.54 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $274.64 | 2025 | Dupixent |
| Blueprint Medicines Corporation | $268.99 | 2023 | Ayvakit |
| Novartis Pharmaceuticals Corporation | $235.50 | 2024-2025 | |
| Amgen INC. | $231.90 | 2022-2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $167.04 | 2025 | Neffy |
| Optinose US, INC. | $109.77 | 2022-2025 | |
| Genentech USA, INC. | $95.15 | 2023-2025 | Xolair |
| Pfizer INC. | $64.20 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $33.18 | 2023 | |
| Csl Behring | $23.91 | 2025 | Haegarda |
| Grifols USA, LLC | $23.39 | 2024 | Xembify |
| Kowa Pharmaceuticals America, INC. | $19.68 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.75 | 2025 | Cuvitru |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Hook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.